CMAJ • January 6, 2009; 180 (1). doi:10.1503/cmaj.071027.
© 2009 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Résumé
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dagenais, G. R.
Right arrow Articles by Bogaty, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dagenais, G. R., MD
Right arrow Articles by Bogaty, P., MD
Related Collections
Right arrowRelated Articles

Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease

Gilles R. Dagenais, MD, Annie St-Pierre, PhD, Patrick Gilbert, MD, Benoît Lamarche, PhD, Jean-Pierre Després, PhD, Paul-Marie Bernard, MSc and Peter Bogaty, MD

From the Institut universitaire de cardiologie et pneumologie (Dagenais, St-Pierre, Després, Bogaty), the Institut de nutraceutiques et aliments fonctionnels (Lamarche) and the Faculté de médicine (Bernard), Université Laval, Québec, Que.; and the Centre Hospitalier de l'Université de Montréal (Gilbert), Montréal, Que.


Figure 116
View larger version (65K):
[in this window]
[in a new window]

  		Box 1.

 

View this table:
[in this window]
[in a new window]

  		Table 1.

 

Figure 116
View larger version (23K):
[in this window]
[in a new window]

  		Figure 1: Cardiovascular and total mortality among men with diabetes or cardiovascular disease (CVD). *Adjusted for age (dichotomized as < 60 yr and ≥ 60 yr). Note: CI = confidence interval.

 

Figure 216
View larger version (24K):
[in this window]
[in a new window]

  		Figure 2: Unadjusted Kaplan–Meier survival curves for cardiovascular disease mortality among men with neither diabetes nor cardiovascular disease, men with diabetes and no cardiovascular disease, and men with a first acute cardiovascular event and no diabetes. Log-rank test: p < 0.001.

 

Figure 316
View larger version (24K):
[in this window]
[in a new window]

  		Figure 3: Unadjusted Kaplan–Meier survival curves for all-cause mortality among men with neither diabetes nor cardiovascular disease, men with diabetes and no cardiovascular disease, and men with a first acute cardiovascular event and no diabetes. Log-rank test: p < 0.001.

 

View this table:
[in this window]
[in a new window]

  		Table 2.